[Developmental abnormalities in children and adolescents following treatment of rheumatoid arthritis].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D000367:Age Factors; D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use; D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002648:Child; D006128:Growth / Q000187:drug effects*; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use; D007989:Libido / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D045930:Anabolic Agents; D007213:Indomethacin
O zaburzeniach rozwojowych u dzieci i młodziezy w nastepstwie farmakoterapii reumatoidalnego zapalenia stawów